GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of the 503B thing finally clicked for me and I want to write it down — 30 comments in the full submission. View in context.
1.7k
c/compounding·submitted 10 months ago by u/yannick_barros

the 503B thing finally clicked for me and I want to write it down

Pricingbranch of 6 comments

the 503B thing finally clicked for me and I want to write it down. Change my mind, genuinely — I have no stake in being right about this. Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything. The intake asked me three…

Read the full submission and all 30 comments →

This branch

6 comments, started 10 months ago
u/camila_sandvik90 points·10 months ago

Asked for the beyond-use date basis and got a real answer with a stability reference attached. Not universal, apparently.

replysharereportpermalink
u/fatima_kowalski73 points·10 months ago

Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.

replysharereportpermalink
u/yannick_petrov21 points·10 months ago

salt forms are the recurring argument and the answer is boring

replysharereportpermalink
u/kavya_kravchenko11 points·10 months ago

Yes — asking which facility, by name, is the single most useful question and most clinics will answer it.

replysharereportpermalink
[deleted]29 points·10 months ago

[deleted]

replysharereportpermalink
u/rina_sobczak15 points·10 months ago

That figure is the starting material purity, not the finished preparation potency. Two different tests.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →